# Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension

> **NCT00868894** · PHASE1,PHASE2 · COMPLETED · sponsor: **Santen Inc.** · enrollment: 49 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** DE-104 medium concentration
- **DRUG:** DE-104 high concentration
- **DRUG:** Placebo
- **DRUG:** 0.005% latanoprost

## Key facts

- **NCT ID:** NCT00868894
- **Lead sponsor:** Santen Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-06
- **Target enrollment:** 49 (ACTUAL)
- **Last updated:** 2011-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00868894

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00868894, "Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00868894. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*